Joseph Eid - 17 Feb 2026 Form 4 Insider Report for GERON CORP (GERN)

Role: EVP, R&D; Chief Medical Office
Signature: /s/ Michelle Robertson, attorney-in-fact
Issuer symbol: GERN
Transactions as of: 17 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 19 Feb 2026, 18:11:23 UTC
Previous filing: 12 Nov 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Eid Joseph	EVP, R&D; Chief Medical Office	C/O GERON CORPORATION, 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY	/s/ Michelle Robertson, attorney-in-fact	19 Feb 2026	0001780247

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GERN	Stock Option (Right to Buy)	Award	$0	+2,220,000		$0.000000	2,220,000	17 Feb 2026	Common Stock	2,220,000	$1.80	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests in 48 equal monthly installments commencing on March 17, 2026, provided that the Reporting Person provides continuous service to the Issuer on each such vesting date.